跳至主要内容
临床试验/ISRCTN12471415
ISRCTN12471415已完成不适用

Effectiveness of patient support programme for the treatment of hepatitis C

Department of Health (Taiwan)0 个研究点目标入组 500 人开始时间: 2006年6月2日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adult patients who have never received interferon and who had at least 2000 copies of HCV ribonucleic acid per ml (RNA/ml) of serum with polymerase chain reaction (PCR) assay, serum aspartate aminotransferase (AST) above the upper limit of normal within six months before entry into study and a liver biopsy result consistent with the diagnosis of chronic hepatitis C.

排除标准

  • Patients with:
  • 1. Neutropenia (<1500/ml of neutrophils)
  • 2. Anemia (Hb <12g/dl of hemoglobin)
  • 3. Thrombocytopenia (platelet <90000/ml)
  • 4. Human immunodeficiency virus (HIV) infection
  • 5. Decompensated liver disease
  • 6. Serum creatinine >1.5 times the upper limit of normal
  • 7. Poorly-controlled psychiatric disease
  • 8. Unwilling to receive contraception

研究者

发起方
Department of Health (Taiwan)

相似试验